Clostridium difficile vaccine - Aviex Technologies

Drug Profile

Clostridium difficile vaccine - Aviex Technologies

Alternative Names: AVX-101 - Aviex; PROPHYLACTIC CLOSTRIDIUM difficile (C. difficile) VACCINE - Aviex

Latest Information Update: 02 Aug 2016

Price : $50

At a glance

  • Originator Aviex Technologies
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Clostridium infections

Most Recent Events

  • 02 Aug 2016 Preclinical trials in Clostridium infections (Prevention) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top